艾德生物：股东厦门科英完成减持1.00%股份

Group 1 - The shareholder Xiamen Keying Investment Partnership has completed its reduction plan by selling 3.9252 million shares through block trading, which accounts for 1.00% of the total share capital [1] - After the reduction, Xiamen Keying's shareholding ratio has decreased to 4.06% [1]